CRI Worldwide

CRI Worldwide specializes in early-stage clinical research with expertise in psychiatry, pain management, neurology, and pediatrics. It operates both inpatient and outpatient trials for patients and healthy volunteers. The company’s Phase I units are located within fully accredited medical and psychiatric hospitals to ensure patient safety. Following its acquisition of Lifetree Clinical Research in 2011, it became one of the largest providers of patient population Phase I services in the U.S., offering access to over six million people across three sites. No specific drug development results are reported since it acts as a service provider. The company assists sponsors with complex trial design and execution to expedite transition to later-stage proof-of-concept studies.